Adial Pharmaceuticals Inc.
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$0.63avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Adial Pharmaceuticals Inc. in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was 1620 Investment Advisors, Inc. ($2K).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| 1620 Investment Advisors, Inc. | 0.00% | No change | 3,600 | $2K |
"% of holder's portfolio" is ADIAL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.